Ulysses Management’s Amgen AMGN Stock Holding History

Ulysses Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$4.5M	–	45
2016 Q1	$4.5M	Buy	+30,000	New	+$4.46M	0.49%	28

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ulysses Management's AMGN Position: Q4 2016 in Review

Ulysses Management sold out of Amgen (AMGN) in Q4 2016, closing a stake of 7,000 shares — an estimated $1.17M sold.

Ulysses Management first reported a position in AMGN in Q2 2016 and held it in 2 quarters. The position peaked at $1.17M in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

Ulysses Management reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
Ulysses Management sold 7,000 Amgen shares in Q4 2016, an estimated $1.17M.
Ulysses Management first reported a position in Amgen in Q2 2016 and held it in 2 quarters.
Ulysses Management's Amgen position peaked at $1.17M in Q3 2016.
1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Ulysses Management's 13F filing for Q4 2016, filed 14 Feb 2017.